NO872094D0 - Fremgangsmaate ved fremstilling av dbh-inhiberende forbindelser. - Google Patents

Fremgangsmaate ved fremstilling av dbh-inhiberende forbindelser.

Info

Publication number
NO872094D0
NO872094D0 NO872094A NO872094A NO872094D0 NO 872094 D0 NO872094 D0 NO 872094D0 NO 872094 A NO872094 A NO 872094A NO 872094 A NO872094 A NO 872094A NO 872094 D0 NO872094 D0 NO 872094D0
Authority
NO
Norway
Prior art keywords
dbh
procedure
preparation
inhibitive compounds
inhibitive
Prior art date
Application number
NO872094A
Other languages
English (en)
Other versions
NO872094L (no
Inventor
Joseph Alan Finkelstein
Lawrence Ivan Kruse
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Publication of NO872094D0 publication Critical patent/NO872094D0/no
Publication of NO872094L publication Critical patent/NO872094L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO872094A 1986-05-23 1987-05-19 Fremgangsmaate for fremstilling av dbh-inhiberende forbindelser. NO872094L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86643786A 1986-05-23 1986-05-23

Publications (2)

Publication Number Publication Date
NO872094D0 true NO872094D0 (no) 1987-05-19
NO872094L NO872094L (no) 1987-11-24

Family

ID=25347617

Family Applications (1)

Application Number Title Priority Date Filing Date
NO872094A NO872094L (no) 1986-05-23 1987-05-19 Fremgangsmaate for fremstilling av dbh-inhiberende forbindelser.

Country Status (15)

Country Link
EP (1) EP0246888A3 (no)
JP (1) JPS62283967A (no)
KR (1) KR870011109A (no)
CN (1) CN87103808A (no)
AU (1) AU7334487A (no)
DK (1) DK251087A (no)
FI (1) FI872249A (no)
HU (1) HU201530B (no)
IL (1) IL82542A0 (no)
NO (1) NO872094L (no)
NZ (1) NZ220347A (no)
PH (1) PH23506A (no)
PT (1) PT84904B (no)
ZA (1) ZA873653B (no)
ZW (1) ZW9087A1 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4628059A (en) * 1985-10-31 1986-12-09 Smithklein Beckman Corporation Dopamine-β-hydroxylase inhibitors
DE4230466A1 (de) * 1992-09-11 1994-03-17 Basf Ag Verfahren zur katalytischen Herstellung von Kondensationsprodukten des Formaldehyds
WO2011126903A2 (en) 2010-03-30 2011-10-13 Verseon, Inc. Multisubstituted aromatic compounds as inhibitors of thrombin
CN110179795A (zh) 2013-03-15 2019-08-30 维颂公司 作为丝氨酸蛋白酶抑制剂的多取代芳族化合物的制药用途
AU2014238478B2 (en) 2013-03-15 2018-07-19 Verseon Corporation Halogenopyrazoles as inhibitors of thrombin
US10189810B2 (en) 2014-09-17 2019-01-29 Verseon Corporation Pyrazolyl-substituted pyridone compounds as serine protease inhibitors
HRP20221287T1 (hr) 2015-02-27 2023-02-03 Verseon International Corporation Supstituirani pirazolni spojevi kao inhibitori serin proteaze

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5634673A (en) * 1979-08-31 1981-04-06 Nippon Nohyaku Co Ltd 1,2,4-triazoles and agricultural and horticultural fungicide containing the same
JPS59164783A (ja) * 1983-03-11 1984-09-17 Nippon Soda Co Ltd トリアゾ−ルジスルフイド誘導体及びその製造方法
PT78388B (en) * 1983-04-12 1986-09-15 Smithkline Beckman Corp Dopamine-beta-hydroxylase inhibitors
US4628059A (en) * 1985-10-31 1986-12-09 Smithklein Beckman Corporation Dopamine-β-hydroxylase inhibitors

Also Published As

Publication number Publication date
HU201530B (en) 1990-11-28
HUT47920A (en) 1989-04-28
NO872094L (no) 1987-11-24
JPS62283967A (ja) 1987-12-09
KR870011109A (ko) 1987-12-21
AU7334487A (en) 1987-11-26
CN87103808A (zh) 1987-12-09
ZA873653B (en) 1988-08-31
ZW9087A1 (en) 1987-09-02
DK251087A (da) 1987-11-24
FI872249A0 (fi) 1987-05-21
PH23506A (en) 1989-08-16
EP0246888A2 (en) 1987-11-25
PT84904B (en) 1989-07-17
PT84904A (en) 1987-06-01
FI872249A (fi) 1987-11-24
NZ220347A (en) 1990-05-28
EP0246888A3 (en) 1988-09-28
DK251087D0 (da) 1987-05-18
IL82542A0 (en) 1987-11-30

Similar Documents

Publication Publication Date Title
NO885106D0 (no) FremgangsmŸte ved fremstilling av cytidin-derivater.
NO900830L (no) Fremgangsmaate for fremstilling av piperidinforbindelser.
NO852124L (no) Fremgangsmaate ved fremstilling av kinolonderivater.
NO170071C (no) Fremgangsmaate ved fremstilling av klordioksyd.
NO166032C (no) Fremgangsmaate ved fremstilling av triklormonosilan.
NO880068L (no) Fremgangsmaate ved fremstilling av heteroaryl-3-okso-propannitrilderivater.
NO874467D0 (no) Fremgangsmaate for fremstilling av 3-pyrrolidinoler.
NO884665L (no) Fremgangsmaate ved fremstilling av 9-oh-alkoksyguanin.
NO165676C (no) Fremgangsmaate ved fremstilling av pyrrolidonderivater.
NO852810L (no) Fremgangsmaate ved fremstilling av fluorallylaminderivater.
NO872809L (no) FremgangsmŸte ved fremstilling av 5-amino-alicylsyre.
NO860794L (no) Fremgangsmaate ved fremstilling av klordioksyd.
NO872094D0 (no) Fremgangsmaate ved fremstilling av dbh-inhiberende forbindelser.
NO873400L (no) Fremgangsmaate for fremstilling av sulfidfri alkalivaeske.
NO903666D0 (no) Fremgangsmaate for fremstilling av pyrrolokinolinforbindelser.
NO864386D0 (no) Fremgangsmaate ved fremstilling av uretaner.
NO861239L (no) Fremgangsmaate ved fremstilling av klordioksyd.
NO881055L (no) Fremgangsmaate ved fremstilling av okso-isoindolinyl-derivater.
NO168941C (no) Fremgangsmaate for fremstilling av mercaptoacylprolin.
NO904535L (no) Fremgangsmaate for fremstilling av fenoksy-heterocykliske forbindelser.
NO870543L (no) Fremgangsmaate ved fremstilling av 4-acetylisokinolinonforbindelser.
NO875403D0 (no) Fremgangsmaate ved fremstilling av poelse.
NO880345L (no) Fremgangsmaate for fremstilling av alkyl-tert-butyletere.
NO163863C (no) Fremgangsmaate ved fremstilling av polyfenylenoksyd.
NO875253D0 (no) Fremgangsmaate for fremstilling av methyl-4-oxo-5-tetradecynoat.